Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

USNAUSANA HEALTH SCIENCES INC

NYSE · CIK 0000896264
Filer categoryAccelerated filer
Entity typeoperating
SIC2833 Medicinal Chemicals & Botanical Products
FY end0103
XBRL facts425

Identity from submissions API

NameUSANA HEALTH SCIENCES INC
CIK0000896264
TickersUSNA
ExchangesNYSE
Entity typeoperating
CategoryAccelerated filer
SIC2833 Medicinal Chemicals & Botanical Products
EIN870500306
LEI—
Fiscal year end0103
State of incorporationUT UT
Phone8019547100
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • USANA INC (1996-07-23T00:00:00.000Z → 2000-04-27T00:00:00.000Z)
Business address
3838 WEST PARKWAY BLVD.
SALT LAKE CITY
UT
84120-6336
UT
Mailing address
3838 WEST PARKWAY BLVD.
3838 WEST PARKWAY BLVD.
SALT LAKE CITY
UT
84120-6336
UT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

2102 filing rows loaded from submissions recent; extra archives: CIK0000896264-submissions-001.json (1100 filings, 1996-05-15 to 2017-11-14).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 10-Q/A 10-Q/A 0000896264-26-000077 001-35024 261574639 34 6146933 1 1
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127175 005-55565 261553682 34 11107
2026-11-12 10-Q 10-Q 0000896264-26-000070 001-35024 261545919 34 6143053 1 1
2026-11-03 8-K 8-K 2.02,7.01,9.01 0000896264-26-000064 001-35024 261517496 34 794278 1 1
2026-10-23 4 FORM 4 0001261778-26-000009 8773
2026-10-23 4 FORM 4 0001673356-26-000010 7286
2026-10-23 4 FORM 4 0001709352-26-000010 7283
2026-10-23 4 FORM 4 0001203302-26-000014 7142
2026-10-23 4 FORM 4 0001763161-26-000013 8728
2026-10-23 4 FORM 4 0001824992-26-000010 7273
2026-10-23 4 FORM 4 0001889687-26-000008 8721
2026-10-05 8-K 8-K 1.01,2.03,9.01 0000896264-26-000060 001-35024 261440892 34 188735 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001037389-26-000057 005-55565 261273886 34 9576
2026-08-13 10-Q 10-Q 0000896264-26-000056 001-35024 261272486 34 6017091 1 1
2026-08-04 8-K 8-K 2.02,7.01,9.01 0000896264-26-000050 001-35024 261239096 34 763616 1 1
2026-07-27 4 FORM 4 0002032126-26-000010 8355
2026-07-27 4 FORM 4 0002053876-26-000006 8378
2026-07-27 4 FORM 4 0001261778-26-000007 8773
2026-07-27 4 FORM 4 0001673356-26-000008 7285
2026-07-27 4 FORM 4 0001709352-26-000008 7283
2026-07-27 4 FORM 4 0001203302-26-000012 7142
2026-07-27 4 FORM 4 0001763161-26-000011 8728
2026-07-27 4 FORM 4 0001824992-26-000008 7273
2026-07-27 4 FORM 4 0001889687-26-000006 8721
2026-06-18 4 FORM 4 0001775522-26-000008 5072
2026-06-16 144 xsl144X01/primary_doc.xml 0001950047-26-006236 001-35024 261095758 33 6787
2026-06-16 4 FORM 4 0000896264-26-000044 6358
2026-06-15 144 xsl144X01/primary_doc.xml 0001950047-26-006159 001-35024 261092262 33 6075
2026-06-15 11-K 11-K 0000896264-26-000042 001-35024 261088714 34 1631448 1 1
2026-06-08 4 FORM 4 0001565541-26-000010 4880
2026-06-08 144 xsl144X01/primary_doc.xml 0001950047-26-005769 001-35024 261073175 33 6643
2026-06-01 4 FORM 4 0001824992-26-000006 4875
2026-05-29 4 FORM 4 0001565541-26-000008 4883
2026-05-28 144 xsl144X01/primary_doc.xml 0001950047-26-005257 001-35024 261038266 33 7702
2026-05-28 4 FORM 4 0001203346-26-000008 4927
2026-05-27 144 xsl144X01/primary_doc.xml 0001950047-26-005170 001-35024 261027274 33 6585
2026-05-26 4 FORM 4 0001203302-26-000010 4932
2026-05-20 8-K 8-K 5.07 0000896264-26-000036 001-35024 261004358 34 154134 1 1
2026-05-12 10-Q 10-Q 0000896264-26-000034 001-35024 26969237 34 4604648 1 1
2026-05-11 4 FORM 4 0001261778-26-000005 5823
2026-05-11 4 FORM 4 0001709352-26-000006 5804
2026-05-11 4 FORM 4 0001763161-26-000008 5780
2026-05-11 4 FORM 4 0001824992-26-000004 5795
2026-05-11 4 FORM 4 0001673356-26-000006 5807
2026-05-11 4 FORM 4 0001203302-26-000008 5773
2026-05-11 4 FORM 4 0001889687-26-000004 5773
2026-05-08 4 FORM 4 0001748208-26-000008 4878
2026-05-07 144 xsl144X01/primary_doc.xml 0001950047-26-004173 001-35024 26953021 33 5470
2026-05-05 8-K 8-K 2.02,7.01,9.01 0000896264-26-000030 001-35024 26943489 34 737405 1 1
2026-04-27 4 FORM 4 0001261778-26-000003 8769
2026-04-27 4 FORM 4 0001673356-26-000004 7281
2026-04-27 4 FORM 4 0001709352-26-000004 7278
2026-04-27 4 FORM 4 0001203302-26-000006 7138
2026-04-27 4 FORM 4 0001763161-26-000006 8724
2026-04-27 4 FORM 4 0001824992-26-000002 7269
2026-04-27 4 FORM 4 0001889687-26-000002 8717
2026-04-07 ARS ARS 0000896264-26-000027 001-35024 26845546 34 39196130
2026-04-07 DEF 14A DEF 14A 0000896264-26-000026 001-35024 26845525 34 199028759 1 1
2026-03-30 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-037181 005-55565 26816484 34 27040
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002522 005-55565 26805087 34 7264
2026-03-20 4 FORM 4 0001203302-26-000004 4666
2026-03-16 10-K 10-K 0000896264-26-000021 001-35024 26756096 34 12616597 1 1
2026-03-03 4 FORM 4 0002032126-26-000008 4794
2026-03-03 144 xsl144X01/primary_doc.xml 0001950047-26-002106 001-35024 26715339 33 7245
2026-03-03 4 FORM 4 0001691991-26-000005 8364
2026-03-03 4 FORM 4 0001775522-26-000006 8589
2026-03-03 4 FORM 4 0001565541-26-000006 8586
2026-03-03 4 FORM 4 0001203346-26-000006 8630
2026-03-03 4 FORM 4 0001748208-26-000006 8583
2026-03-03 4 FORM 4 0001353496-26-000006 8594
2026-03-03 4 FORM 4 0002032126-26-000006 8227
2026-03-03 4 FORM 4 0002053876-26-000004 8245
2026-02-23 4 FORM 4 0001748208-26-000004 7168
2026-02-23 4 FORM 4 0002032126-26-000004 5556
2026-02-23 4 FORM 4 0002053876-26-000002 5574
2026-02-23 4 FORM 4 0000896264-26-000015 5692
2026-02-23 4 FORM 4 0001775522-26-000004 5699
2026-02-23 4 FORM 4 0001565541-26-000004 5695
2026-02-23 4 FORM 4 0001203346-26-000004 5740
2026-02-23 4 FORM 4 0001353496-26-000004 5703
2026-02-20 144 xsl144X01/primary_doc.xml 0001950047-26-001554 001-35024 26659922 33 5941
2026-02-18 8-K 8-K 2.02,7.01,9.01 0000896264-26-000014 001-35024 26644868 34 868184 1 1
2026-02-11 8-K/A 8-K/A 5.02,9.01 0000896264-26-000012 001-35024 26621639 34 340239 1 1
2026-02-10 4 FORM 4 0002032126-26-000002 17889
2026-02-10 4 FORM 4 0001691991-26-000002 18249
2026-02-10 4 FORM 4 0001775522-26-000002 18910
2026-02-10 4 FORM 4 0001565541-26-000002 18904
2026-02-10 4 FORM 4 0001203346-26-000002 18951
2026-02-10 4 FORM 4 0001748208-26-000002 18905
2026-02-10 4 FORM 4 0001353496-26-000002 18923
2026-01-26 4 FORM 4 0000896264-26-000010 8634
2026-01-26 4 FORM 4 0001673356-26-000002 7147
2026-01-26 4 FORM 4 0001709352-26-000002 7144
2026-01-26 4 FORM 4 0001763161-26-000002 8590
2026-01-26 4 FORM 4 0001203302-26-000002 7004
2026-01-26 4 FORM 4 0000896264-26-000009 7135
2026-01-26 4 FORM 4 0000896264-26-000007 8583
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000354204-26-000300 005-55565 26546479 34 8783
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000730 005-55565 26545947 34 10959
2026-01-12 8-K 8-K 2.02,7.01,9.01 0000896264-26-000005 001-35024 26524584 34 177182 1 1
2026-01-08 8-K 8-K 5.02,7.01,9.01 0000896264-26-000002 001-35024 26517615 34 176875 1 1
2025-12-11 4 FORM 4 0001697433-25-000004 4751
2025-12-11 4 FORM 4 0002032126-25-000003 4606
2025-12-10 144 xsl144X01/primary_doc.xml 0001950047-25-010107 001-35024 251562657 33 7125
2025-11-10 4 FORM 4 0001673356-25-000005 4750
2025-11-05 10-Q 10-Q 0000896264-25-000224 001-35024 251455091 34 5817803 1 1
2025-11-04 4 FORM 4 0001203302-25-000006 4606
2025-11-03 4 FORM 4 0001824992-25-000006 4738
2025-10-27 4 FORM 4 0000896264-25-000215 8591
2025-10-27 4 FORM 4 0001261778-25-000004 8634
2025-10-27 4 FORM 4 0001673356-25-000003 7148
2025-10-27 4 FORM 4 0001709352-25-000005 7145
2025-10-27 4 FORM 4 0001203302-25-000004 7005
2025-10-27 4 FORM 4 0001824992-25-000004 7136
2025-10-27 4 FORM 4 0001889687-25-000003 8584
2025-10-22 8-K 8-K 2.02,7.01,9.01 0000896264-25-000213 001-35024 251410262 34 730394 1 1
2025-10-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001027796-25-000049 005-55565 251392394 34 7108
2025-10-09 8-K 8-K 2.02,7.01,9.01 0000896264-25-000210 001-35024 251385194 34 240531 1 1
2025-10-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000354204-25-001292 005-55565 251384406 34 8641
2025-09-05 4 OWNERSHIP DOCUMENT 0001104659-25-087682 7243
2025-08-28 144 xsl144X01/primary_doc.xml 0001950047-25-006472 001-35024 251273310 33 5939
2025-08-08 4 FORM 4 0000896264-25-000207 4606
2025-08-05 10-Q 10-Q 0000896264-25-000205 001-35024 251185758 34 5738088 1 1
2025-07-31 4 FORM 4 0000896264-25-000200 4755
2025-07-30 144 xsl144X01/primary_doc.xml 0001950047-25-005259 001-35024 251166942 33 5358
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-001071 005-55565 251160766 34 6300
2025-07-28 4 FORM 4 0000896264-25-000198 8240
2025-07-28 4 FORM 4 0000896264-25-000196 8220
2025-07-28 4 FORM 4 0000896264-25-000194 8574
2025-07-28 4 FORM 4 0000896264-25-000192 8584
2025-07-28 4 FORM 4 0000896264-25-000190 7136
2025-07-28 4 FORM 4 0000896264-25-000188 7005
2025-07-28 4 FORM 4 0000896264-25-000186 8591
2025-07-28 4 FORM 4 0000896264-25-000184 7145
2025-07-28 4 FORM 4 0000896264-25-000182 7148
2025-07-28 4 FORM 4 0000896264-25-000180 8634
2025-07-22 8-K 8-K 2.02,7.01,9.01 0000896264-25-000178 001-35024 251140364 34 750651 1 1
2025-07-01 8-K 8-K 1.01,2.03,9.01 0000896264-25-000175 001-35024 251094956 34 2557043 1 1
2025-06-20 11-K 11-K 0000896264-25-000170 001-35024 251060956 34 196673
2025-06-10 4 FORM 4 0000896264-25-000166 4739
2025-05-29 4 FORM 4 0000896264-25-000164 4808
2025-05-27 144 xsl144X01/primary_doc.xml 0001950047-25-003514 001-35024 25990132 33 5941
2025-05-21 S-8 S-8 0000896264-25-000162 333-287476 25973182 33 243381
2025-05-21 4 FORM 4 0000896264-25-000160 5636
2025-05-21 4 FORM 4 0000896264-25-000158 5686
2025-05-21 4 FORM 4 0000896264-25-000156 5643
2025-05-21 4 FORM 4 0000896264-25-000154 5667
2025-05-21 4 FORM 4 0000896264-25-000152 5658
2025-05-21 4 FORM 4 0000896264-25-000150 5670
2025-05-21 4 FORM 4 0000896264-25-000148 5636
2025-05-20 8-K 8-K 5.02,5.07,8.01 0000896264-25-000144 001-35024 25965486 34 550135 1 1
2025-05-12 4 FORM 4 0000896264-25-000142 4788
2025-05-09 144 xsl144X01/primary_doc.xml 0001972362-25-000413 001-35024 25930205 33 5410
2025-05-06 4 FORM 4 0000896264-25-000140 8625
2025-05-06 4 FORM 4 0000896264-25-000138 7139
2025-05-06 4 FORM 4 0000896264-25-000136 7136
2025-05-06 4 FORM 4 0000896264-25-000134 8582
2025-05-06 4 OWNERSHIP DOCUMENT 0001104659-25-045016 7241
2025-05-06 4 FORM 4 0000896264-25-000132 8355
2025-05-06 4 FORM 4 0000896264-25-000130 7127
2025-05-06 4 FORM 4 0000896264-25-000128 8575
2025-05-06 10-Q 10-Q 0000896264-25-000126 001-35024 25916695 34 4492744 1 1
2025-05-01 DEFA14A DEFA14A 0000896264-25-000122 001-35024 25903939 34 215731547 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000581 005-55565 25892159 34 6301
2025-04-22 8-K 8-K 2.02,7.01,9.01 0000896264-25-000119 001-35024 25857742 34 564357 1 1
2025-04-16 DEFA14A DEFA14A 0000896264-25-000117 001-35024 25840897 34 215594005 1 1
2025-04-09 ARS ARS 0000896264-25-000113 001-35024 25824492 34 35300281
2025-04-09 DEFA14A DEFA14A 0000896264-25-000111 001-35024 25824469 34 381375
2025-04-04 DEF 14A DEF 14A 0000896264-25-000105 001-35024 25815734 34 199074452 1 1
2025-03-13 4 FORM 4 0000896264-25-000096 4938
2025-03-13 4 FORM 4 0000896264-25-000094 4945
2025-03-12 144 xsl144X01/primary_doc.xml 0001972362-25-000288 001-35024 25733034 33 5364
2025-03-12 144 xsl144X01/primary_doc.xml 0001972362-25-000283 001-35024 25732970 33 5369
2025-03-12 10-K 10-K 0000896264-25-000092 001-35024 25731492 34 11569236 1 1
2025-03-12 4 FORM 4 0000896264-25-000089 4745
2025-03-11 4 FORM 4 0000896264-25-000087 4954
2025-03-10 144 xsl144X01/primary_doc.xml 0001972362-25-000269 001-35024 25725183 33 4845
2025-03-10 4 FORM 4 0000896264-25-000084 4611
2025-03-07 144 xsl144X01/primary_doc.xml 0001972362-25-000258 001-35024 25721163 33 5364
2025-03-07 8-K/A 8-K/A 9.01 0000896264-25-000082 001-35024 25719705 34 4486903 1 1
2025-03-06 144 xsl144X01/primary_doc.xml 0001972362-25-000243 001-35024 25716070 33 4296
2025-03-03 4 FORM 4 0000896264-25-000078 4744
2025-03-03 144 xsl144X01/primary_doc.xml 0001972362-25-000215 001-35024 25700317 33 5361
2025-03-03 4 FORM 4 0000896264-25-000076 5581
2025-03-03 4 FORM 4 0000896264-25-000074 5563
2025-03-03 4 FORM 4 0000896264-25-000072 5699
2025-03-03 4 FORM 4 0000896264-25-000070 5706
2025-03-03 4 FORM 4 0000896264-25-000068 5711
2025-03-03 4 FORM 4 0000896264-25-000066 5702
2025-03-03 4 FORM 4 0000896264-25-000064 5747
2025-03-03 4 FORM 4 0000896264-25-000062 5703
2025-03-03 4 FORM 4 0000896264-25-000060 5701
2025-03-03 4 FORM 4 0000896264-25-000058 5696
2025-03-03 4 FORM 4 0000896264-25-000056 4728
2025-02-25 8-K 8-K 2.02,7.01,9.01 0000896264-25-000054 001-35024 25663223 34 1308418 1 1
2025-02-11 4 FORM 4 0000896264-25-000052 13061
2025-02-11 4 FORM 4 0000896264-25-000050 13312
2025-02-11 4 FORM 4 0000896264-25-000048 13755
2025-02-11 4 FORM 4 0000896264-25-000046 10821
2025-02-11 4 FORM 4 0000896264-25-000044 13750
2025-02-11 4 FORM 4 0000896264-25-000042 13797
2025-02-11 4 FORM 4 0000896264-25-000040 13757
2025-02-11 4 FORM 4 0000896264-25-000038 13750
2025-02-11 4 FORM 4 0000896264-25-000036 13750
2025-02-10 4 FORM 4 0000896264-25-000034 13062
2025-02-10 4 FORM 4 0000896264-25-000032 13312
2025-02-10 4 FORM 4 0000896264-25-000030 13755
2025-02-10 4 FORM 4 0000896264-25-000028 10821
2025-02-10 4 FORM 4 0000896264-25-000026 13750
2025-02-10 4 FORM 4 0000896264-25-000024 13797
2025-02-10 4 FORM 4 0000896264-25-000022 13760
2025-02-10 4 FORM 4 0000896264-25-000020 13750
2025-02-10 4 FORM 4 0000896264-25-000018 13747
2025-02-03 4 FORM 4 0000896264-25-000016 8634
2025-02-03 4 FORM 4 0000896264-25-000014 7148
2025-02-03 4 FORM 4 0000896264-25-000012 7145
2025-02-03 4 FORM 4 0000896264-25-000010 8591
2025-02-03 4 FORM 4 0000896264-25-000008 7004
2025-02-03 4 FORM 4 0000896264-25-000006 7136
2025-02-03 4 FORM 4 0000896264-25-000004 8584
2025-02-03 3 FORM 3 0000896264-25-000002 4470
2024-12-23 8-K 8-K 1.01,2.01,7.01,9.01 0000896264-24-000235 001-35024 241570248 34 4604918 1 1
2024-11-18 4 OWNERSHIP DOCUMENT 0001104659-24-119995 7269
2024-11-05 4 FORM 4 0000896264-24-000232 8636
2024-11-05 4 FORM 4 0000896264-24-000230 7150
2024-11-05 4 FORM 4 0000896264-24-000228 7147
2024-11-05 4 FORM 4 0000896264-24-000226 8593
2024-11-05 4 FORM 4 0000896264-24-000224 8366
2024-11-05 10-Q 10-Q 0000896264-24-000222 001-35024 241426608 34 4298701 1 1
2024-11-05 4 FORM 4 0000896264-24-000221 7138
2024-11-05 4 FORM 4 0000896264-24-000218 8586
2024-10-22 8-K 8-K 2.02,7.01,9.01 0001628280-24-043281 001-35024 241386447 34 414048 1 1
2024-10-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001027796-24-000041 005-55565 241382953 34 6954
2024-08-14 4 FORM 4 0000896264-24-000212 4752
2024-08-13 144 xsl144X01/primary_doc.xml 0001972362-24-001141 001-35024 241203513 33 7023
2024-08-08 4 FORM 4 0000896264-24-000210 4612
2024-08-06 10-Q 10-Q 0000896264-24-000208 001-35024 241178156 34 4138115 1 1
2024-08-05 4 FORM 4 0000896264-24-000206 7166
2024-08-05 4 FORM 4 0000896264-24-000204 7150
2024-08-05 4 FORM 4 0000896264-24-000202 7147
2024-08-05 4 FORM 4 0000896264-24-000200 8593
2024-08-05 4 FORM 4 0000896264-24-000198 7006
2024-08-05 4 FORM 4 0000896264-24-000196 7138
2024-08-05 4 FORM 4 0000896264-24-000194 8586
2024-08-01 4 FORM 4 0000896264-24-000189 4745
2024-07-31 144 xsl144X01/primary_doc.xml 0001972362-24-001036 001-35024 241163427 33 5375
2024-07-29 4 FORM 4 0000896264-24-000187 5495
2024-07-29 3 FORM 3 0000896264-24-000184 3201
2024-07-25 4 FORM 4 0000896264-24-000182 8608
2024-07-23 8-K 8-K 2.02,7.01,9.01 0000896264-24-000180 001-35024 241134594 34 431796 1 1
2024-06-20 11-K 11-K 0000896264-24-000178 001-35024 241056513 34 185910
2024-06-14 4 OWNERSHIP DOCUMENT 0001104659-24-071894 9839
2024-06-11 4 OWNERSHIP DOCUMENT 0001104659-24-070582 7172
2024-06-07 144 xsl144X01/primary_doc.xml 0001104659-24-069757 001-35024 241030869 33 4757
2024-05-23 4 FORM 4 0000896264-24-000174 4754
2024-05-22 144 xsl144X01/primary_doc.xml 0001972362-24-000764 001-35024 24974429 33 5360
2024-05-07 4 FORM 4 0000896264-24-000172 4984
2024-05-07 144 xsl144X01/primary_doc.xml 0001972362-24-000608 001-35024 24923642 33 5943
2024-05-07 144 xsl144X01/primary_doc.xml 0001972362-24-000607 001-35024 24923627 33 4894
2024-05-07 4 FORM 4 0000896264-24-000170 4798
2024-05-07 8-K 8-K 5.07 0000896264-24-000168 001-35024 24921657 34 163172 1 1
2024-05-07 10-Q 10-Q 0000896264-24-000165 001-35024 24921578 34 3659270 1 1
2024-05-06 4/A FORM 4/A 0000896264-24-000160 5164
2024-05-03 4 FORM 4 0000896264-24-000157 5691
2024-05-03 4 FORM 4 0000896264-24-000155 5648
2024-05-03 4 FORM 4 0000896264-24-000153 5674
2024-05-03 4 FORM 4 0000896264-24-000150 5663
2024-05-03 4 FORM 4 0000896264-24-000148 5675
2024-05-03 4 FORM 4 0000896264-24-000146 5641
2024-05-03 4 FORM 4 0000896264-24-000145 5644
2024-05-02 144 xsl144X01/primary_doc.xml 0001972362-24-000565 001-35024 24910200 33 6507
2024-05-02 4 FORM 4 0000896264-24-000142 4955
2024-04-30 8-K 8-K 2.02,7.01,9.01 0000896264-24-000138 001-35024 24897209 34 425171 1 1
2024-04-25 4 FORM 4 0000896264-24-000136 7200
2024-04-25 4 FORM 4 0000896264-24-000134 7184
2024-04-25 4 FORM 4 0000896264-24-000132 7183
2024-04-25 4 FORM 4 0000896264-24-000130 8628
2024-04-25 4 FORM 4 0000896264-24-000128 7041
2024-04-25 4 FORM 4 0000896264-24-000126 7172
2024-04-25 4 FORM 4 0000896264-24-000124 8623
2024-03-27 ARS FORM ARS 0001140361-24-015496 001-35024 24786898 34 915781
2024-03-27 DEFA14A FORM DEFA14A 0001140361-24-015493 001-35024 24786882 34 835697
2024-03-22 DEF 14A DEF 14A 0000896264-24-000119 001-35024 24774558 34 198930336 1 1
2024-03-11 144 xsl144X01/primary_doc.xml 0001972362-24-000391 001-35024 24739688 33 5912
2024-03-11 144 xsl144X01/primary_doc.xml 0001972362-24-000390 001-35024 24739679 33 5361
2024-03-11 4 FORM 4 0000896264-24-000115 4752
2024-03-11 4 FORM 4 0000896264-24-000113 4823
2024-03-07 4 FORM 4 0000896264-24-000111 4760
2024-03-06 144 xsl144X01/primary_doc.xml 0001972362-24-000342 001-35024 24727346 33 5897
2024-03-05 4 FORM 4 0000896264-24-000109 4940
2024-03-05 144 xsl144X01/primary_doc.xml 0001972362-24-000334 001-35024 24722948 33 5894
2024-03-05 4 FORM 4 0000896264-24-000107 4745
2024-03-05 4 FORM 4 0000896264-24-000105 4611
2024-03-04 144 xsl144X01/primary_doc.xml 0001972362-24-000305 001-35024 24717128 33 4296
2024-03-04 144 xsl144X01/primary_doc.xml 0001972362-24-000303 001-35024 24717095 33 5452
2024-03-04 4 FORM 4 0000896264-24-000103 4729
2024-03-04 4 FORM 4 0000896264-24-000100 4766
2024-03-04 4 FORM 4 0000896264-24-000097 4949
2024-03-04 4 FORM 4 0000896264-24-000095 4936
2024-03-01 144 xsl144X01/primary_doc.xml 0001972362-24-000289 001-35024 24712479 33 4836
2024-02-29 144 xsl144X01/primary_doc.xml 0001972362-24-000258 001-35024 24705539 33 5375
2024-02-29 144 xsl144X01/primary_doc.xml 0001972362-24-000256 001-35024 24705525 33 5893
2024-02-27 10-K 10-K 0000896264-24-000093 001-35024 24687257 34 9936961 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022203 005-55565 24629769 34 13188
2024-02-13 SC 13G/A usna-13g_20231231.txt 0001037389-24-000064 005-55565 24623407 34 13476
2024-02-12 4 FORM 4 0000896264-24-000079 10868
2024-02-12 4 FORM 4 0000896264-24-000077 10646
2024-02-12 4 FORM 4 0000896264-24-000075 10936
2024-02-12 4 FORM 4 0000896264-24-000073 9407
2024-02-12 4 FORM 4 0000896264-24-000071 10881
2024-02-12 4 FORM 4 0000896264-24-000069 9397
2024-02-12 4 FORM 4 0000896264-24-000067 10913
2024-02-12 4 FORM 4 0000896264-24-000065 10873
2024-02-12 4 FORM 4 0000896264-24-000063 10865
2024-02-12 4 FORM 4 0000896264-24-000061 10865
2024-02-08 4 FORM 4 0000896264-24-000059 13752
2024-02-08 4 FORM 4 0000896264-24-000057 13312
2024-02-08 4 FORM 4 0000896264-24-000055 13760
2024-02-08 4 FORM 4 0000896264-24-000053 10820
2024-02-08 4 FORM 4 0000896264-24-000051 13765
2024-02-08 4 FORM 4 0000896264-24-000049 10810
2024-02-08 4 FORM 4 0000896264-24-000047 13797
2024-02-08 4 FORM 4 0000896264-24-000045 13762
2024-02-08 4 FORM 4 0000896264-24-000043 13750
2024-02-08 4 FORM 4 0000896264-24-000041 13749
2024-02-06 8-K USANA HEALTH SCIENCES, INC. 8-K 2.02,7.01,9.01 0001157523-24-000176 001-35024 24600462 34 532631 1 1
2024-02-06 4 FORM 4 0000896264-24-000039 8591
2024-02-06 4 FORM 4 0000896264-24-000037 8369
2024-02-06 4 FORM 4 0000896264-24-000035 8597
2024-02-06 4 FORM 4 0000896264-24-000033 7128
2024-02-06 4 FORM 4 0000896264-24-000031 8604
2024-02-06 4 FORM 4 0000896264-24-000029 8586
2024-02-06 4 FORM 4 0000896264-24-000027 8635
2024-02-06 4 FORM 4 0000896264-24-000025 8587
2024-02-06 4 FORM 4 0000896264-24-000023 8589
2024-02-06 4 FORM 4 0000896264-24-000021 8587
2024-01-26 4 FORM 4 0000896264-24-000016 8630
2024-01-26 4 FORM 4 0000896264-24-000013 7043
2024-01-26 4 FORM 4 0000896264-24-000011 7186
2024-01-26 4 FORM 4 0000896264-24-000009 7174
2024-01-26 4 FORM 4 0000896264-24-000006 7185
2024-01-26 4 FORM 4 0000896264-24-000004 7202
2024-01-26 4 FORM 4 0000896264-24-000002 8625
2024-01-24 SC 13G/A us90328m1071_012424.txt 0001086364-24-002660 005-55565 24557799 34 13804
2023-12-14 4 OWNERSHIP DOCUMENT 0001104659-23-126099 7054
2023-12-14 4 FORM 4 0000896264-23-000033 4664
2023-12-12 144 xsl144X01/primary_doc.xml 0001972362-23-001165 001-35024 231482434 33 4239
2023-11-07 4 xslF345X05/form4-11072023_081133.xml 0001415889-23-014830 4557
2023-11-07 10-Q 10-Q 0000896264-23-000030 001-35024 231382947 34 4115116 1 1
2023-11-03 144 xsl144X01/primary_doc.xml 0001972362-23-000888 001-35024 231377305 33 4211
2023-10-25 4 xslF345X05/form4-10252023_101057.xml 0001415889-23-014557 6952
2023-10-25 4 xslF345X05/form4-10252023_101024.xml 0001415889-23-014556 6975
2023-10-25 4 xslF345X05/form4-10252023_091028.xml 0001415889-23-014555 7003
2023-10-25 4 xslF345X05/form4-10252023_091038.xml 0001415889-23-014554 6987
2023-10-25 4 xslF345X05/form4-10252023_091004.xml 0001415889-23-014553 6986
2023-10-25 4 xslF345X05/form4-10252023_091042.xml 0001415889-23-014552 8430
2023-10-25 4 xslF345X05/form4-10252023_091006.xml 0001415889-23-014551 8425
2023-10-24 8-K USANA HEALTH SCIENCES, INC. 8-K 2.02,7.01,9.01 0001157523-23-001529 001-35024 231342752 34 527289 1 1
2023-08-18 4 xslF345X05/form4-08182023_060807.xml 0001415889-23-012400 4785
2023-08-17 144 xsl144X01/primary_doc.xml 0001972362-23-000669 001-35024 231182427 33 5279
2023-08-16 4 xslF345X05/form4-08162023_110849.xml 0001415889-23-012331 4789
2023-08-15 144 xsl144X01/primary_doc.xml 0001972362-23-000655 001-35024 231175922 33 6527
2023-08-15 4 xslF345X05/form4-08152023_030826.xml 0001415889-23-012246 4788
2023-08-11 144 xsl144X01/primary_doc.xml 0001972362-23-000640 001-35024 231165632 33 5398
2023-08-08 10-Q 10-Q 0000896264-23-000024 001-35024 231150936 34 4056119 1 1
2023-08-03 4 xslF345X05/form4-08032023_080847.xml 0001415889-23-011810 4557
2023-08-01 4 xslF345X05/form4-08012023_050801.xml 0001415889-23-011634 4747
2023-08-01 4 xslF345X05/form4-08012023_050818.xml 0001415889-23-011633 4595
2023-07-31 144 xsl144X01/primary_doc.xml 0001972362-23-000529 001-35024 231128566 33 5328
2023-07-31 4 xslF345X05/form4-07312023_020736.xml 0001415889-23-011582 4586
2023-07-28 144 xsl144X01/primary_doc.xml 0001972362-23-000525 001-35024 231124495 33 6300
2023-07-28 4 xslF345X05/form4-07282023_030723.xml 0001415889-23-011543 4750
2023-07-27 144 xsl144X01/primary_doc.xml 0001972362-23-000512 001-35024 231119651 33 4700
2023-07-26 4/A xslF345X05/form4a-07262023_090704.xml 0001415889-23-011500 8724
2023-07-26 4/A xslF345X05/form4a-07262023_090701.xml 0001415889-23-011497 7301
2023-07-26 4/A xslF345X05/form4a-07262023_090708.xml 0001415889-23-011496 7285
2023-07-26 4/A xslF345X05/form4a-07262023_090708.xml 0001415889-23-011495 7284
2023-07-26 4/A xslF345X05/form4a-07262023_090704.xml 0001415889-23-011493 7251
2023-07-26 4/A xslF345X05/form4a-07262023_090723.xml 0001415889-23-011492 7273
2023-07-26 4/A xslF345X05/form4a-07262023_090729.xml 0001415889-23-011491 8729
2023-07-26 4/A xslF345X05/form4a-07262023_080700.xml 0001415889-23-011490 5799
2023-07-25 4 xslF345X05/form4-07252023_100759.xml 0001415889-23-011464 8427
2023-07-25 4 xslF345X05/form4-07252023_100759.xml 0001415889-23-011463 7004
2023-07-25 4 xslF345X05/form4-07252023_090758.xml 0001415889-23-011462 6988
2023-07-25 4 xslF345X05/form4-07252023_090755.xml 0001415889-23-011461 6987
2023-07-25 4 xslF345X05/form4-07252023_090736.xml 0001415889-23-011460 8432
2023-07-25 4 xslF345X05/form4-07252023_090702.xml 0001415889-23-011459 6954
2023-07-25 4 xslF345X05/form4-07252023_090712.xml 0001415889-23-011458 6976
2023-07-25 4 xslF345X05/form4-07252023_090725.xml 0001415889-23-011457 5501
2023-07-25 8-K USANA HEALTH SCIENCES, INC. 8-K 2.02,7.01,9.01 0001157523-23-001145 001-35024 231108593 34 474339 1 1
2023-06-21 11-K 11-K 0000896264-23-000015 001-35024 231030183 34 179346
2023-06-16 4 xslF345X04/form4-06162023_040616.xml 0001415889-23-009874 4596
2023-06-15 144 xsl144X01/primary_doc.xml 0001972362-23-000404 001-35024 231018666 33 4792
2023-06-15 4 xslF345X04/form4-06152023_060616.xml 0001415889-23-009816 4602
2023-05-19 144 xsl144X01/primary_doc.xml 0001972362-23-000195 001-35024 23941674 33 5324
2023-05-12 8-K/A USANA HEALTH SCIENCES, INC. 8-K/A 5.02 0001157523-23-000832 001-35024 23915900 34 159927 1 1
2023-05-11 8-K USANA HEALTH SCIENCES, INC. 8-K 5.07 0001157523-23-000825 001-35024 23911227 34 180416 1 1
2023-05-10 144 xsl144X01/primary_doc.xml 0001972362-23-000111 001-35024 23908178 33 5324
2023-05-09 10-Q 10-Q 0000896264-23-000010 001-35024 23901257 34 3770257 1 1
2023-05-09 4 xslF345X04/form4-05092023_040541.xml 0001415889-23-007614 4760

Latest XBRL company facts

One latest value per concept from companyfacts (425 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 18.49M 2026-11-06 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
dei EntityPublicFloat Entity Public Float USD 328.00M 2025-06-27 2025 FY 10-K 2026-03-16 0000896264-26-000021
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 37.43M 2024-12-29 2026-01-03 DEF 14A 2026-04-07 0000896264-26-000026
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 950,947 2024-12-29 2026-01-03 DEF 14A 2026-04-07 0000896264-26-000026
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.58M 2024-12-29 2026-01-03 DEF 14A 2026-04-07 0000896264-26-000026
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 49 2024-12-29 2026-01-03 DEF 14A 2026-04-07 0000896264-26-000026
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 25 2024-12-29 2026-01-03 DEF 14A 2026-04-07 0000896264-26-000026
invest DerivativeNotionalAmount Derivative, Notional Amount USD 110.00M 2019-06-29 2019 Q2 10-Q 2019-08-06 0001562762-19-000169
us-gaap AccountsAndNotesReceivableNet Accounts and Financing Receivable, after Allowance for Credit Loss USD 6.87M 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 17.66M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 3.37M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.50M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 134.58M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -10.98M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 91.42M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 2.38M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 10.26M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 316,000 2017-01-01 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 12.02M 2015-01-04 2016-01-02 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD 5.31M 2012-12-30 2013-06-29 2013 Q2 10-Q 2013-08-08 0001104659-13-061566
us-gaap AdvertisingExpense Advertising Expense USD 43.16M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.01M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap AllowanceForDoubtfulOtherReceivablesCurrent Allowance for Doubtful Other Receivables, Current USD 96,000 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 19.32M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 2.73M 2017-01-01 2017-12-30 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap Assets Assets USD 708.47M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap AssetsCurrent Assets, Current USD 290.24M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 62.72M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) USD 3.01M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory Business Acquisition, Purchase Price Allocation, Current Assets, Inventory (Deprecated 2013-01-31) USD 1.70M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) USD 4.66M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable (Deprecated 2013-01-31) USD 2.55M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities Business Acquisition, Purchase Price Allocation, Current Liabilities, Other Liabilities (Deprecated 2013-01-31) USD 535,000 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 10.54M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount Business Acquisition, Goodwill, Expected Tax Deductible Amount USD 52.32M 2012-12-29 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill (Deprecated 2013-01-31) USD 41.00M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets (Deprecated 2013-01-31) USD 3.38M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment (Deprecated 2013-01-31) USD 1.52M 2010-08-16 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 43.17M 2010-01-03 2011-01-01 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 527.27M 2010-01-03 2011-01-01 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -548,000 2023-01-01 2023-12-30 2023 FY 10-K 2024-02-27 0000896264-24-000093
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 338,000 2022-12-31 2023 FY 10-K 2024-02-27 0000896264-24-000093
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 548,000 2022-12-31 2023 FY 10-K 2024-02-27 0000896264-24-000093
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 26,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 178.91M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 348,000 2013-12-28 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 71.36M 2017-01-01 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 181.90M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 181.90M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 20.66M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 18.48M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 18.48M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CommonStockValue Common Stock, Value, Issued USD 18,000 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -14.22M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -8.46M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -22.68M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 11.32M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 10.64M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 9.96M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 156.49M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 99.37M 2017-12-31 2018-06-30 2018 Q2 10-Q 2018-08-08 0001104659-18-050458
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 994,000 2018-12-29 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 36.33M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 37.19M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 855,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 6.63M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap DeferredCompensationLiabilityCurrentAndNoncurrent Deferred Compensation Liability, Current and Noncurrent USD 3.14M 2023-12-30 2024 Q1 10-Q 2024-05-07 0000896264-24-000165
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 914,000 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -6.85M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 345,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 29.79M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap DeferredIncomeTaxesAndOtherAssetsNoncurrent Deferred Income Taxes and Other Assets, Noncurrent USD 27.21M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -3.14M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -7.14M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 27.91M 2024-12-28 2023 FY 10-K 2025-03-12 0000896264-25-000092
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 4.86M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 12.05M 2024-12-28 2023 FY 10-K 2025-03-12 0000896264-25-000092
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD 3.10M 2014-06-29 2014-09-27 2014 Q3 10-Q 2014-11-06 0001104659-14-077633
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -628,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAndOtherLiabilitiesNoncurrent Deferred Tax and Other Liabilities, Noncurrent USD 4.89M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 6.44M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 224.57M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 18.16M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 6.22M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 22.32M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 5.27M 2019-09-28 2019 Q3 10-Q 2019-11-05 0001562762-19-000275
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 45.90M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 9.67M 2016-01-02 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 3.35M 2018-12-29 2018 FY 10-K 2019-02-26 0001047469-19-000707
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.77M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 2.65M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 125,000 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.65M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsOtherComprehensiveLoss Deferred Tax Assets, Other Comprehensive Loss USD 3.94M 2016-12-31 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 834,000 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 173.93M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 38.19M 2018-12-29 2018 FY 10-K 2019-02-26 0001047469-19-000707
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.30M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 6.54M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD 1.71M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 178.67M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 23.58M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 4.43M 2016-01-02 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 6.44M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxLiabilitiesGrossCurrent Deferred Tax Liabilities, Gross, Current USD 4.43M 2016-01-02 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 5.43M 2019-09-28 2019 Q3 10-Q 2019-11-05 0001562762-19-000275
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 2.72M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxLiabilitiesOtherComprehensiveIncome Deferred Tax Liabilities, Other Comprehensive Income USD 759,000 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 1.59M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 4.97M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains Deferred Tax Liabilities, Unrealized Currency Transaction Gains USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0000896264-23-000004
us-gaap DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfDomesticSubsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Domestic Subsidiaries USD 3.08M 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.01 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.06 2012-01-01 2012-12-29 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.06 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap Depreciation Depreciation USD 13.84M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 24.07M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap DerivativeAssets Derivative Asset USD 240,000 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 0 2020-09-26 2020 Q3 10-Q 2020-11-03 0001437749-20-022365
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -1.07M 2024-12-29 2025-09-27 2025 Q3 10-Q 2025-11-05 0000896264-25-000224
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 255,000 2023-12-31 2024-09-28 2024 Q3 10-Q 2024-11-05 0000896264-24-000222
us-gaap DerivativeLiabilities Derivative Liability USD 344,000 2026-04-04 2026 Q1 10-Q 2026-05-12 0000896264-26-000034
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 470,000 2022-01-02 2022-04-02 2023 Q1 10-Q 2023-05-09 0000896264-23-000010
us-gaap DerivativeNotionalAmount Derivative, Notional Amount USD 70.06M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap DerivativeNumberOfInstrumentsHeld Derivative, Number of Instruments Held pure 0 2021-10-02 2022 Q3 10-Q 2021-11-10 0001437749-21-026119
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.05 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.05 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.445 2024-12-29 2025-06-28 2026 Q2 10-Q 2026-08-13 0000896264-26-000056
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.244 2023-12-31 2024-12-28 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.026 2023-12-31 2024-12-28 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 20.69M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0.498 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.152 2023-12-31 2024-12-28 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.033 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.01 2023-12-31 2024-12-28 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.003 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.016 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.013 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0.906 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.012 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 10.79M 2017-01-01 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2.67M 2019-12-29 2020-09-26 2020 Q3 10-Q 2020-11-03 0001437749-20-022365
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 3.55M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 20.65M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 22.90M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 2.81M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 20.00M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount USD 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 12.02M 2015-01-04 2016-01-02 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 12.02M 2015-01-04 2016-01-02 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap ExciseAndSalesTaxes Excise and Sales Taxes USD 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 27.92M 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 613,000 2019-12-29 2020-06-27 2020 Q2 10-Q 2020-08-04 0001562762-20-000269
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 29.99M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 124.20M 2024-12-23 2023 FY 10-K 2025-03-12 0000896264-25-000092
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 27.84M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 18.36M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 7.23M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 17.82M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 18.00M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 18.02M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 137.26M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 107.28M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ForeignCurrencyContractAssetFairValueDisclosure Foreign Currency Contract, Asset, Fair Value Disclosure USD 4,000 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ForeignCurrencyContractsLiabilityFairValueDisclosure Foreign Currency Contracts, Liability, Fair Value Disclosure USD 64,000 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ForeignEarningsRepatriated Foreign Earnings Repatriated USD 12.56M 2017-01-01 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -4,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap Goodwill Goodwill USD 109.26M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 127.37M 2023-12-31 2024-12-28 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 29.14M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 437,000 2026-04-05 2026-07-04 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap GoodwillGross Goodwill, Gross USD 144.93M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 35.66M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 29.14M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap GoodwillTranslationAdjustments Goodwill, Translation Adjustments (Deprecated 2016-01-31) USD -509,000 2015-01-04 2016-01-02 2015 FY 10-K 2016-03-01 0001047469-16-010629
us-gaap GrossProfit Gross Profit USD 522.88M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 0 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 1,000 2018-12-29 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 46,000 2018-12-29 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment USD 8.64M 2013-12-28 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap HeldToMaturitySecuritiesCurrent Debt Securities, Held-to-maturity, Current USD 63.54M 2018-12-29 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 63.49M 2018-12-29 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2026-07-05 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -56.25M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -4.24M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 97.78M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 98.65M 2021-01-03 2021-07-03 2022 Q2 10-Q 2021-08-11 0001437749-21-019479
us-gaap IncomeTaxesPaid Income Taxes Paid USD 27.61M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 37.18M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 1.02M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 23.64M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 31.99M 2012-01-01 2012-12-29 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 36.50M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 683,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxReconciliationDeductionsQualifiedProductionActivities Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount USD 856,000 2016-01-03 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -267,000 2017-01-01 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 8.72M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.38M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -38,000 2017-01-01 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 684,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 545,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 37.65M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 339,000 2016-01-03 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD 554,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 329,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 722,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -10.49M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -8.08M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.45M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 38.58M 2015-01-03 2015 FY 10-K 2016-03-01 0001047469-16-010629
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 163.14M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 120.41M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InterestExpense Interest Expense USD 52,000 2023-12-31 2024-03-30 2024 Q1 10-Q 2024-05-07 0000896264-24-000165
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 278,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 473,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 51.70M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InventoryNet Inventory, Net USD 84.08M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 9.23M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 27.67M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 499,000 2025-09-27 2025 Q3 10-Q 2025-11-05 0000896264-25-000224
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 4.72M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InventoryWriteDown Inventory Write-down USD 4.57M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.68M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap LeaseCost Lease, Cost USD 7.97M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 19.64M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 122,000 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 6.40M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 803,000 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.14M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.97M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.20M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.15M 2019-09-28 2019 Q3 10-Q 2019-11-05 0001562762-19-000275
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.68M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap Liabilities Liabilities USD 138.38M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 708.47M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap LiabilitiesCurrent Liabilities, Current USD 112.25M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid (Deprecated 2014-01-31) USD 7.02M 2013-12-29 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap LifeInsuranceCorporateOrBankOwnedAmount Life Insurance, Corporate or Bank Owned, Amount USD 5.43M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap LineOfCredit Long-term Line of Credit USD 0 2016-01-02 2015 FY 10-K 2016-03-01 0001047469-16-010629
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 0 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap LineOfCreditFacilityIncreaseDecreaseForPeriodNet Line of Credit Facility, Increase (Decrease), Net USD -8.92M 2018-12-30 2019-12-28 2020 Q2 10-Q 2020-08-04 0001562762-20-000269
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 75.00M 2020-06-27 2020 Q2 10-Q 2020-08-04 0001562762-20-000269
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 66.00M 2016-04-02 2016 Q1 10-Q 2016-05-11 0001104659-16-120054
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -17.76M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -50.13M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001104659-17-066924
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -10.17M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -8.89M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001104659-17-066924
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 45.04M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 68.65M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001104659-17-066924
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -19.42M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NetIncomeLossAttributableToRedeemableNoncontrollingInterest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest USD -8.46M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 37.58M 2023-12-31 2024-09-28 2024 Q3 10-Q 2024-11-05 0000896264-24-000222
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2023-12-31 2024-12-28 2023 FY 10-K 2025-03-12 0000896264-25-000092
us-gaap NoncurrentAssets Long-Lived Assets USD 137.09M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.33M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NotesReduction Notes Reduction USD 86,000 2017-01-01 2017-12-30 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 3 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 3 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap NumberOfReportingUnits Number of Reporting Units reporting_unit 3 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingExpenses Operating Expenses USD 530.45M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7.57M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OperatingLeaseCost Operating Lease, Cost USD 7.97M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 8.32M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 17.96M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.65M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 12.31M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeasePayments Operating Lease, Payments USD 8.01M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 22.95M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 4.56M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 25.07M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 9.15M 2018-12-29 2018 FY 10-K 2019-02-26 0001047469-19-000707
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.46M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.96M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 3.83M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 6.15M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 2.51M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 9.15M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 11.24M 2017-12-31 2018-12-29 2018 FY 10-K 2019-02-26 0001047469-19-000707
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.052 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 759,000 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 12.82M 2017-12-30 2017 FY 10-K 2018-02-28 0001047469-18-001146
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 0 2022-01-02 2022-12-31 2022 FY 10-K 2023-02-28 0000896264-23-000004
us-gaap OtherAssetsCurrent Other Assets, Current USD 4.85M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OtherAssetsFairValueDisclosure Other Assets, Fair Value Disclosure USD 44.54M 2016-10-01 2016 Q3 10-Q 2016-11-09 0001104659-16-155810
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 64.17M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax (Deprecated 2012-01-31) USD 695,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-10 0001104659-12-035865
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 400,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-10 0001104659-12-035865
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) USD -295,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-10 0001104659-12-035865
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD 5.91M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -3.66M 2013-12-29 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 705,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD 51.23M 2011-01-02 2011-12-31 2011 FY 10-K 2012-03-14 0001047469-12-002617
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 5.20M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherIncome Other Income USD 1.32M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 94.59M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 21.26M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherNoncashExpense Other Noncash Expense USD 80,000 2012-01-01 2012-12-29 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.93M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 9.87M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OtherReceivables Other Receivables USD 12.62M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 8.09M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 2.24M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsHeldtomaturitySecurities Other-than-temporary Impairment Loss, Debt Securities, Held-to-maturity, before Tax USD 0 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap PaymentsForHedgeInvestingActivities Payments for Hedge, Investing Activities USD 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PaymentsForLossesAndLossAdjustmentExpense Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid USD 11.85M 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 1.75M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2022-01-02 2022-12-31 2022 FY 10-K 2023-02-28 0000896264-23-000004
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 2.38M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PaymentsToAcquireAssetsInvestingActivities Payments to Acquire Assets, Investing Activities USD 0 2023-01-01 2023-12-30 2023 FY 10-K 2024-02-27 0000896264-24-000093
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap PaymentsToAcquireHeldToMaturitySecurities Payments to Acquire Held-to-maturity Securities USD 0 2019-12-29 2021-01-02 2020 FY 10-K 2021-03-02 0001437749-21-004694
us-gaap PaymentsToAcquireLandHeldForUse Payments to Acquire Land Held-for-use USD 7.45M 2015-01-04 2015-04-04 2015 Q1 10-Q 2015-05-13 0001104659-15-037648
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 7,000 2016-01-03 2016-12-31 2018 FY 10-K 2019-02-26 0001047469-19-000707
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 9.32M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PaymentsToAcquireTradingSecuritiesHeldforinvestment Payments to Acquire Trading Securities Held-for-investment USD 0 2022-01-02 2022-12-31 2022 FY 10-K 2023-02-28 0000896264-23-000004
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 1.38M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 22.22M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PrepaidInsurance Prepaid Insurance USD 2.68M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable USD 0 2023-01-01 2023-12-30 2023 FY 10-K 2024-02-27 0000896264-24-000093
us-gaap ProceedsFromHedgeInvestingActivities Proceeds from Hedge, Investing Activities USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 390,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 9.00M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities USD 63.54M 2018-12-30 2019-12-28 2022 FY 10-K 2022-03-01 0001437749-22-004802
us-gaap ProceedsFromPreviousAcquisition Proceeds from Previous Acquisition USD 865,000 2024-12-29 2025-09-27 2025 Q3 10-Q 2025-11-05 0000896264-25-000224
us-gaap ProceedsFromRecoveriesOfLoanPreviouslyChargedOff Proceeds, Financing Receivable, Previously Written Off, Recovery USD 4.80M 2017-12-31 2018-12-29 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 66,000 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 10.97M 2013-12-29 2015-01-03 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -27.88M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 212.23M 2023-12-30 2023 FY 10-K 2024-02-27 0000896264-24-000093
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 94.60M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 5.03M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 43.33M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 383,000 2015-01-04 2016-01-02 2015 FY 10-K 2016-03-01 0001047469-16-010629
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 23.00M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 10.69M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 2.75M 2025-03-29 2025 Q1 10-Q 2025-05-06 0000896264-25-000126
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 328,000 2017-12-30 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 2.74M 2024-12-28 2023 FY 10-K 2025-03-12 0000896264-25-000092
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.98M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap RestructuringCharges Restructuring Charges USD 6.46M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap RestructuringReserve Restructuring Reserve USD 2.99M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 446.30M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 679.38M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap Revenues Revenues USD 824.12M 2019-12-29 2020-09-26 2020 Q3 10-Q 2020-11-03 0001437749-20-022365
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.80M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 7.95M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 292.00M 2017-12-31 2018-03-31 2018 Q1 10-Q 2018-05-09 0001104659-18-031650
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 257.30M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 10.26M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 5.17M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 49,000 2011-12-31 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 37 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 49,000 2012-01-01 2012-12-29 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 11.48M 2016-01-03 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 44.29 2012-01-01 2012-12-29 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 63.16 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2016-01-03 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.475 2016-01-03 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.011 2016-01-03 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 10.00M 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 8.86M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 821,000 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 69.2 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.94M 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 3,000 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 45,000 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 6.79M 2013-12-29 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 50,000 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 35.41 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 13.09M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.13M 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 70 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) shares 1.14M 2013-12-29 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 54.6 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 70.75 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 70.75 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 116.06 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap SharePrice Share Price USD/shares 19.44 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 526.76M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) USD 364.20M 2017-12-30 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2 2016-11-22 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap StockIssued1 Stock Issued USD 17.72M 2010-01-03 2011-01-01 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 189,000 2018-12-30 2019-12-28 2019 FY 10-K 2020-02-25 0001562762-20-000071
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 17.72M 2010-01-03 2011-01-01 2012 FY 10-K 2013-03-11 0001047469-13-002524
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 80,000 2012-01-01 2012-12-29 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 0 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 27.74M 2024-12-29 2025-09-27 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2024-06-30 2024-09-28 2024 Q3 10-Q 2024-11-05 0000896264-24-000222
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 27.62M 2019-03-31 2019-06-29 2020 Q2 10-Q 2020-08-04 0001562762-20-000269
us-gaap StockRepurchaseProgramAuthorizedAmount Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) USD 61.18M 2013-12-29 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 150.00M 2021-09-16 2022 Q3 10-Q 2021-11-10 0001437749-21-026119
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) USD 13.62M 2012-12-30 2013-09-28 2013 Q3 10-Q 2013-11-07 0001104659-13-082184
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 33.97M 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap UndistributedEarnings Undistributed Earnings, Basic USD 4.00M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UndistributedEarningsOfDomesticSubsidiaries Undistributed Earnings of Domestic Subsidiaries USD 19.60M 2016-12-31 2016 FY 10-K 2017-03-01 0001047469-17-001138
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 12.30M 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -853,000 2024-12-29 2025-03-29 2025 Q1 10-Q 2025-05-06 0000896264-25-000126
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.54M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 26,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 187,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 384,000 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 1.53M 2021-01-02 2020 FY 10-K 2021-03-02 0001437749-21-004694
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary Unrecorded Unconditional Purchase Obligation, to be Paid, Year One USD 3.86M 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two USD 4.75M 2015-01-03 2014 FY 10-K 2015-03-17 0001047469-15-002349
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 22.00M 2024-12-29 2026-01-03 2025 FY 10-K 2026-03-16 0000896264-26-000021
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 18.46M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares -124,000 2013-12-29 2014-06-28 2014 Q2 10-Q 2014-08-05 0001104659-14-056823
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 81,000 2013-12-29 2014-06-28 2014 Q2 10-Q 2014-08-05 0001104659-14-056823
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 18.46M 2026-01-04 2026-10-03 2026 Q3 10-Q/A 2026-11-19 0000896264-26-000077

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →